about
Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma.3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma.The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cellsNovel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinomaLong non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transitionThree-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma.Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.Sorafenib: 10 years after the first pivotal trial.A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.Surgery for hepatocellular carcinoma presenting with variceal bleeding: The eastern experience.Emerging roles of FGF signaling in hepatocellular carcinoma.A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.Ribonucleotide reductase subunit M2 can be new molecular target and prognostic biomarker of hepatocellular carcinoma.Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation.eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma.HIF-2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial-mesenchymal transition.Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5.Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.Hepatocellular carcinoma in 2017: Two large steps forward, one small step back.Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized (13) C MRSI.Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinomaMelatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction
P2860
Q33828043-75A4DEC0-1101-41D0-92F6-8FDF5617957AQ33860879-B76B8BED-B550-40AB-B54F-0D6DE2117414Q35531154-1F7834EE-FFB9-4024-B12E-616B7766E783Q35739362-28A69800-48B5-4408-8826-04A730DFF406Q35742449-2C705A04-9FA9-4EF0-958F-046339F6BF2DQ35913384-34090BC8-E71C-4ED0-9362-01F3F53724E1Q35936548-95F7CA2A-B8CC-4DA9-9373-614B4458ABF2Q36016223-6F01097C-29BC-4C19-91B9-198269ABBE3BQ36140852-0556F3A4-652B-4FAE-ADB3-8CB1AC422B76Q36414180-F6E65C5B-2188-40C0-B943-969079229731Q36583498-292DE195-21CF-489E-B6E4-C3FA501CDC1CQ36939981-78479896-3B74-4E7D-9824-B7BD0998C73DQ37536645-ECCD4E0B-75BF-44BE-92ED-46BA870862A6Q37688558-BCADD7A3-9FC4-4F57-B3CB-2CB2E838D2A1Q38432256-35660C5D-6B91-4702-868C-CBFAEE8E8F39Q38544841-38385F83-01EE-4709-860A-44CE51E18312Q38764893-B069461A-D6D5-4B18-8CD3-83AD8DB0615FQ38906745-AB210D60-8F5F-43C5-90C2-C9E4919F78ACQ40060996-48004DEE-7358-48EC-AF11-5FFFD708919FQ41055360-7247EC18-4C2A-4D47-8BA4-B2682DB7DEBBQ41876265-69D8A5E9-C634-4BAC-BBD7-AD207CEFE330Q42064611-6772AAE9-E22A-4ACC-8D5A-8DA0C93E9CA4Q42970016-E1B81B39-C98F-4143-B494-784B42D632CCQ45394478-2CCF3025-9592-409A-AEC4-1FABF7A468D8Q47284899-D22ABFC6-728C-4459-ADC3-3CC0BA036BFCQ47608670-1B0C2562-0268-4056-AB48-B22CF4675094Q47831650-E55A9A95-7E7E-48AC-9D10-042643E525E6Q47954829-33A0BA41-3B9B-47E2-B223-53AC6F02C842Q48089437-39527447-06B9-4DE3-B35C-945033904C31Q48141205-2A84BACF-660F-42B2-AF0C-E93F8B189EADQ48282479-7ABE53C1-2B1E-48DE-8A53-0AE371422EB1Q50196083-0D00003E-3F9D-4B1C-85CB-D6C316CC666EQ51326114-CCC530B4-7434-4D3D-B069-4216AADC268FQ52571263-B371163A-012B-43ED-89F9-D98A54DCD545Q52764639-22EBC4DA-79CD-4AE4-8D40-BA0110500A1FQ52926888-8CAEBC3B-3E88-45F0-85DD-28B9B4F861EDQ57816332-80EFD095-9118-4BD4-A1C2-6B9C0B15CEB1Q58753365-32DDA9AF-3278-4C4E-8E45-6D8B9B7C7E2D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HCC therapies--lessons learned.
@en
type
label
HCC therapies--lessons learned.
@en
prefLabel
HCC therapies--lessons learned.
@en
P2860
P356
P1476
HCC therapies--lessons learned.
@en
P2093
Marcus-Alexander Wörns
Peter Robert Galle
P2860
P2888
P304
P356
10.1038/NRGASTRO.2014.10
P407
P577
2014-02-04T00:00:00Z
P6179
1020977034